Hypogammaglobulinemia secondary to B-cell depleting therapies in neuroimmunology: Comparing management strategies

BACKGROUND: Anti-CD20 agents are commonly used in MS, NMOSD, and MOGAD. Few studies have compared strategies to address hypogammaglobulinemia. OBJECTIVE: To compare strategies to manage secondary hypogammaglobulinemia in neuroimmunology patients, including reducing anti-CD20 dose and dosing frequenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Hannah, Vishnevetsky, Anastasia, Chibnik, Lori B., Levy, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291859/
https://www.ncbi.nlm.nih.gov/pubmed/37377746
http://dx.doi.org/10.1177/20552173231182534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291859/
https://www.ncbi.nlm.nih.gov/pubmed/37377746
http://dx.doi.org/10.1177/20552173231182534

Ejemplares similares